Page 8 - Crispr News Today

Xenotransplantation is on the cusp of clinical trials for the first time, now that CRISPR has revolutionized our ability to make pig organs compatible with humans.

Many people know someone with a genetic disease, but few understand how gene mutations work.

One of the most severe complications of HSV is herpetic stromal keratitis (HSK), which affects the cornea of the eye and can lead to visual impairment or even blindness.

Most approved gene therapies today, including those involving CRISPR-Cas9, work their magic on cells removed from the body, after which the edited cells are returned to the patient.

Hereditary Angioedema could soon meet its match in CRISPR gene editing's newest treatment. The first trials for a new CRISPR-based gene therapy for the fatal disorder called hereditary angioedema have reportedly shown promising results.

Nine out of ten people in a trial of a CRISPR treatment for potentially life-threatening inflammatory reactions seem to have been cured

A new technology to increase the visibility of cancer cells to the immune system using CRISPR has been developed and could lead to a new way to treat cancer.

Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.

InnovationRx is your weekly digest of healthcare news. Sign up!

Crispr recently marked a major milestone in medicine. But it's not time for a victory lap—the race is just beginning.